Search results for "Fibrosarcoma"

showing 10 items of 35 documents

Nonepithelial skin tumors with multinucleated giant cells

2013

Recognition of the different types of multinucleated giant cells in neoplastic and pseudotumoral lesions of the skin may be helpful in the differential diagnosis of these tumors. In this review, we will analyze the different types of multinucleated giant cells that can be found in nonepithelial cutaneous tumors and, more importantly, the clinicopathological context in which they are found. Touton giant cells are typically present in juvenile xanthogranuloma, necrobiotic xanthogranuloma, and some subtypes of xanthomas. Giant cells with a ground glass appearance are typically present in the solitary reticulohistiocytoma and multicentric reticulohistiocytosis. Osteoclast-like cells are found i…

Pathologymedicine.medical_specialtySkin NeoplasmsHistiocytosis Non-Langerhans-CellJuvenile xanthogranulomaSoft Tissue NeoplasmsFibromaBiologyGiant CellsPathology and Forensic MedicineTouton giant cellXanthomatosismedicineHumansGiant Cell TumorsNecrobiotic xanthogranulomaHistiocytoma Benign FibrousPlexiform fibrohistiocytic tumorDermatofibrosarcomaGiant Cell TumorsAtypical fibroxanthomamedicine.diseaseGiant cellLipomaPleomorphic lipomaXanthogranuloma JuvenileSeminars in Diagnostic Pathology
researchProduct

Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management

2013

Dermatofibrosarcoma protuberans (DFSP) is a rare superficial tumor characterized by high rates of local recurrence and low risk of metastasis. DFSP occurs most commonly on the trunk and proximal extremities, affects all races, and often develops between the second and fifth decade of life. The tumor grows slowly, typically over years. Histologically, several variants of DFSP have been described and should be well characterized to avoid misdiagnosis with other tumors. These include pigmented (Bednar tumor), myxoid, myoid, granular cell, sclerotic, atrophic DFSP, giant cell fibroblastoma, and DFSP with fibrosarcomatous areas. Of all these variants, only the DFSP with fibrosarcomatous areas is…

Pathologymedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentAntineoplastic AgentsPiperazinesTranslocation GeneticPathology and Forensic MedicineMetastasismedicineDermatofibrosarcoma protuberansHumansbusiness.industryStandard treatmentWide local excisionDermatofibrosarcomaImatinibGiant-cell fibroblastomaMohs Surgerymedicine.diseaseCombined Modality TherapyDermatologyPyrimidinesImatinib mesylateBenzamidesImatinib MesylateNeoplasm Recurrence LocalDifferential diagnosisbusinessmedicine.drugSeminars in Diagnostic Pathology
researchProduct

Fibroblast and Myofibroblast Participation in Malignant Fibrous Histiocytoma (MFH) of Bone

1989

Eight malignant fibrous histiocytomas (MFH) of bone were studied with immunohistochemistry and electron microscopy. Ultrastructurally, fibroblasts and myofibroblasts were the main tumor cells in four cases and abundant in two other cases; these cells showed immunohistochemical positivity to alpha 1-antitrypsin, vimentin and anti-muscle antigen (HHF 35). Moreover, histiocytic-like tumor cells were electron-microscopically detected in four cases, being the main tumor cell type in two of the cases; immunohistochemically these cells expressed positivity to alpha-1-antichymotrypsin (A1ACT), alpha-1-antitrypsin (A1AT) and vimentin. Present results confirm the cellular heterogeneity of MFH of bone…

Pathologymedicine.medical_specialtyVimentinCell BiologyBiologymedicine.diseasePathology and Forensic Medicinemedicine.anatomical_structureCellular heterogeneityAntigenmedicineUltrastructurebiology.proteinImmunohistochemistryFibrosarcomaFibroblastMyofibroblastPathology - Research and Practice
researchProduct

Synthesis and biological evaluation of lipid-like 5-(2-hydroxyethyl)-4-methyl-1,3-thiazole derivatives as potential anticancer and antimicrobial agen…

2015

A series of new lipid-like thiazole derivatives have been synthesized in good yields by O-alkylation of 5-(2-hydroxyethyl)-4-methyl-1,3-thiazole, a thiamine metabolite, under phase transfer catalysis conditions followed by N-alkylation with the aim to obtain potential anticancer and antimicrobial agents. The synthesized cationic amphiphiles and their ether precursors were subjected to in vitro cytotoxic evaluation against monolayer human fibrosarcoma HT-1080 and mouse hepatoma MG-22A tumour cell lines and normal mouse NIH 3T3 fibroblasts and were screened for antimicrobial activity concerning gram-positive and gram-negative bacterial and fungal strains. The synthesized compounds possessed s…

PharmacologyChemistryMetaboliteOrganic ChemistryPharmaceutical ScienceEtherAntimicrobialmedicine.diseaseBiochemistryIn vitrochemistry.chemical_compoundBiochemistryCell cultureIn vivoDrug DiscoverymedicineMolecular MedicineFibrosarcomaThiazoleMedChemComm
researchProduct

Characterization of the metastatic properties of two methylcholantrene-induced fibrosarcoma in mice

1988

MC1 and MC2 murine fibrosarcomas, following intramuscular innplantation in mice, release different numbers of tumor cells into the bloodstream and differ in their lung colonization potential following intravenous inoculation. Since these biological properties could be related to a different degree of maligancy, in vivo and in vitro experiments were performed vvith these two tunnors in an attempt to correlate their spontaneous metas-tatic potential with other parameters related to tunnor cell invasion and metastasis. Following intramuscular inplantation the MC2 fibrosarcoma was observed to have a slow but progressive ability to spontaneously metastasize while the MC1 lacked this capability. …

PloidymetastasisfibrosarcomaExtracellular matrixinvasion
researchProduct

Silyl modification of biologically active compounds. 13. Synthesis, cytotoxicity and antibacterial action ofN-methyl-N-(2-triorganylsiloxyethyl)-1,2,…

2012

A series of N-methyl-N-(2-triorganylsiloxyethyl)-1,2,3,4-tetrahydro(iso)quinolinium iodides has been synthesized via dehydrocondensation reaction of N-(2-hydroxyethyl)-1,2,3,4-tetrahydroisoquinoline, N-(2-hydroxyethyl)-1,2,3,4-tetrahydroquinoline and 4,4-dimethyl-N-(2-hydroxyethyl)-4-sila-1,2,3,4-tetrahydroisoquinoline with trialkyl(aryl)hydrosilanes and subsequent alkylation, and characterized by 1H, 13C and 29Si NMR and mass spectroscopy. The biological activity data exhibited a marked enhancement of inhibitory activity against tumour cell lines and almost all the test bacterial/fungal strains in comparison with their 2-hydroxyethyl precursors. Cytotoxicity in the microgram range against …

SilylationStereochemistryArylBiological activityGeneral ChemistryAlkylationmedicine.diseaseInorganic Chemistrychemistry.chemical_compoundchemistryCell culturemedicineCholineCytotoxicityFibrosarcomaApplied Organometallic Chemistry
researchProduct

Pyrrolo[2,3-h]quinolinones: synthesis and photochemotherapic activity.

2003

A series of derivatives of the new ring system pyrrolo[2,3-h]quinoline-2-one was synthesized and evaluated as photoreagents toward cultured human tumor cells. Remarkable phototoxycity resulted for some derivatives, especially those bearing the phenyl group at the 7-position.

StereochemistryFibrosarcomaClinical BiochemistryPharmaceutical ScienceAntineoplastic AgentsQuinolonesRing (chemistry)BiochemistryChemical synthesischemistry.chemical_compoundStructure-Activity RelationshipDrug DiscoveryTumor Cells CulturedPhenyl groupHumansPhotosensitizerPyrrolesMolecular BiologyPhotosensitizing AgentsChemistryOrganic ChemistryGeneral MedicineIn vitroHuman tumorPhotochemotherapyCell cultureLactamMolecular MedicineDrug Screening Assays AntitumorBioorganicmedicinal chemistry letters
researchProduct

Pyrrolo[2,3-h]quinolinones: A new ring system with potent photoantiproliferative activity

2006

A new class of compounds, the pyrrolo[2,3-h]quinolin-2-ones, nitrogen isosters of the angular furocoumarin Angelicin, was synthesized with the aim of obtaining new photochemotherapeutic agents with increased antiproliferative activity and lower undesired toxic effects than the lead compound. Two synthetic pathways were approached to allow the isolation both of the dihydroderivatives 10-17 and of the aromatic ring system 23. Compounds 10-17 showed a remarkable phototoxicity and a great UVA dose dependence reaching IC(50) values at submicromolar level. Intracellular localization of these compounds has been evaluated by means of fluorescence microscopy using tetramethylrhodamine methyl ester a…

Ultraviolet RaysStereochemistryFibrosarcomaClinical BiochemistryPharmaceutical ScienceHL-60 CellsAdenocarcinomaQuinolonesBiochemistryChemical synthesisMass Spectrometrychemistry.chemical_compoundAngelicinangelicinDrug DiscoverymedicineHumansMolecular BiologyChromatography High Pressure LiquidCell ProliferationFluorescent DyesPhotosensitizing AgentsRhodaminesChemistryFurocoumarinErythrocyte MembraneOrganic ChemistryAcridine orangeProteinsDNAAcridine OrangeIntercalating AgentsMitochondriapyrroloquinolinoneCross-Linking ReagentsMicroscopy FluorescencePhotochemotherapyMechanism of actionMolecular MedicineLipid Peroxidationmedicine.symptomantitumour activityLysosomesPhototoxicityLead compoundDNA DamageMacromolecule
researchProduct

Dermatofibrosarcoma protuberans: estudio de factores pronósticos

2012

Introducción: El dermatofibrosarcoma protubernas (DFSP) es un tumor cutáneo de malignidad intermedia clasificado dentro de los tumores fibrohistiocíticos que tiene una alta tasa de recidivas locales tras extirpaciones con cirugía convencional pero baja capacidad de producir metástasis. Hipótesis: Existen determinadas características del DFSP que condicionan un crecimiento más infiltrativo, asimétrico e impredecible, lo que supone mayor morbilidad para el paciente y una mayor dificultad para su tratamiento. Objetivos: 1.-Realizar un análisis observacional y descriptivo de una serie de casos de DFSP que han sido vistos en el Servicio de Dermatología del IVO, según las características epidemio…

cirugía de Mohsdermatofibrosarcoma protuberansUNESCO::CIENCIAS MÉDICAStumores cutáneos:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Absence of mutation at the GAP-related domain of the neurofibromatosis type 1 gene in sporadic neurofibrosarcomas and other bone and soft tissue sarc…

1995

The NF1 gene encodes neurofibromin, a GTPase-activating protein containing a GAP-related domain (NF1-GRD) that is capable of downregulating ras by stimulating ras intrinsic GTPase activity. We tested 44 sarcomas, nine of which corresponded to sporadic neurofibrosarcomas, for mutations at the NF1-GRD by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique, finding no mutation in every sample tested. We suggest that inactivation of the NF1-GRD by gene mutation seems not to be an important event in the tumorigenesis of sarcomas.

congenital hereditary and neonatal diseases and abnormalitiesCancer ResearchNeurofibromatosis 1DNA Mutational AnalysisBone NeoplasmsSoft Tissue NeoplasmsGTPaseBiologyGene mutationmedicine.disease_causePolymerase Chain ReactionGeneticsmedicineHumansneoplasmsMolecular BiologyGenePolymorphism Single-Stranded ConformationalGeneticsMutationNeurofibromin 1ProteinsSarcomaSingle-strand conformation polymorphismmedicine.diseaseNeurofibromin 1eye diseasesnervous system diseasesNeurofibrosarcomaCancer researchbiology.proteinSarcomaCarcinogenesisCancer Genetics and Cytogenetics
researchProduct